As Bayer continues its mitigation to reach a settlement, Dow Jones is reporting the company could settle its glyphosate (Roundup) legal cases for a sum around $10 billion. A settlement would mean the end of the company’s legal battles concerning glyphosate.
 
Bayer, who bought the inventor of glyphosate, Monsanto, is dealing with under 50,000 plaintiffs who claim the product has caused cancer. So far, the company has lost three glyphosate trials—with some pending appeal outcomes.
 
The company recently said it would consider a settlement that is “financially reasonable and represents finality [for future and current cases],” according to Liam Condon, president of Bayer Crop Science, in a previous interview with AgWeb.
 
Click Here to read more.